Upside down you’re turning me…let’s talk about 340B
Participants will receive informative information on Optimizing the 340 B Drug discount program from faculty subject matter experts that have direct experience implementing the following ideal practices are presenting.
Faculty experts will present information with a focus on how the attendee can use the information to implement it in their setting, including key takeaway points with each presentation. The audience will be engaged in polling and can ask questions to further their knowledge and confidence.
Target Audience
This activity is intended for pharmacists and pharmacy technicians.
Learning Objectives
Pharmacists learning objectives
At the conclusion of this activity, pharmacists should be able to:
- Identify current pharmacy regulatory from relevant agencies such as FDA, CMS, DEA, and USP.
- Describe the role of GLNs for tracking and tracing.
- Explain proposed 2023 changes to Medicare reimbursement with operational changes required to implement them.
- Explain 2022 and 2023 HRSA Program Integrity Results.
- Demonstrate how 340B savings are used to benefit patient care.
Pharmacy technician learning objectives
At the conclusion of this activity, pharmacy technicians should be able to:
- Identify current pharmacy regulatory from relevant agencies such as FDA, CMS, DEA, and USP.
- Describe the role of GLNs for tracking and tracing.
- Explain proposed 2023 changes to Medicare reimbursement with operational changes required to implement them.
- Explain 2022 and 2023 HRSA Program Integrity Results.
- Demonstrate how 340B savings are used to benefit patient care.
Faculty
Greg Medley, PharmD, MBA, 340B ACE, FASCP
Senior Manager
Vizient, Inc.
Planning committee
Madalene Klocke, BA
Project Manager
Vizient, Inc.
Mallory Fiorenza, PharmD, BCPS, BCCCP
Pharmacy Executive Director
Vizient, Inc.
Identification, Mitigation, and Disclosure of Relevant Financial Relationships
As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
Disclosure of Financial Relationships:
Absence of Relevant Financial Relationships
Vizient, Inc., Jointly Accredited for Interprofessional Continuing Education, defines companies to be ineligible as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.
No one in a position to control the content of this educational activity have relevant financial relationships with ineligible companies.
Statement of content validity
Vizient, Inc. educational activities are intended to assist healthcare teams advance their professional responsibilities in accordance with the definition of continuing education. It is the policy of Vizient, Inc. to review and ensure that all content and recommendations for patient care within accredited CE is evidenced-based, based on current science and clinical reasoning while ensuring the content is fair and balanced. All recommendations must conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation. Vizient, Inc. does not permit accredited continuing education if it advocates for unscientific approaches to diagnosis or therapy, or if the education promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.
FDA off-label/unapproved usage
Faculty/Presenters are required to identify any new and evolving topics for which there is a lower/absence of evidence base. This is to ensure that our content does not advocate for, or promote, practices that are not, or not yet adequately based on current science, evidence, and clinical reasoning. Faculty/Presenters are required to disclose any discussion of (1) off-label/unapproved or investigational uses of FDA approved commercial products or devices and/or (2) products or devices not yet approved in the United States.
Disclaimer: The education provided through this activity is for continuing education purposes only. The views and opinions expressed in this activity are those of the faculty/presenters and do not necessarily reflect the views of Vizient, Inc.
Joint Accreditation Statement:
In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Designation Statement(s):
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.0 ACPE credit hours.
Universal Activity Number: JA0006103-0000-23-328-L04-P
Universal Activity Number: JA0006103-0000-23-328-L04-T
OTHER
Vizient, Inc. will award all other healthcare professionals who successfully complete the activity a Certificate of Participation. Various state license boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re- certification. It is the responsibility of the participant to contact their state licensing board and/or certifying body for verification on credit eligibility reciprocity.
Available Credit
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Technician
- 1.00 General CE - Attendance